Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease-Reference-Cited by-同舟云学术

Renin-Angiotensin Inhibition and Outcomes in HFrEF and Advanced Kidney Disease

Published:2023-07 Issue:7 Volume:136 Page:677-686
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Patel Samir,Lam Phillip H.,Kanonidis Evangelos I.,Ahmed Amiya A.,Raman Venkatesh K.,Wu Wen-Chih,Rossignol Patrick,Arundel Cherinne,Faselis Charles,Kanonidis Ioannis E.,Deedwania Prakash,Allman Richard M.,Sheikh Farooq H.,Fonarow Gregg C.,Pitt Bertram,Ahmed Ali

Publisher

Elsevier BV

Subject

General Medicine

Reference48 articles.

1. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

2. Medical management of heart failure with reduced ejection fraction in patients with advanced renal disease;Hein;JACC Heart Fail,2019

3. Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications;Ahmed;J Am Geriatr Soc,2002

4. Effects of angiotensin-converting enzyme inhibitors in systolic heart failure patients with chronic kidney disease: a propensity score analysis;Ahmed;J Card Fail,2006

5. Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease;Ahmed;Am J Med,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of patients with heart failure and chronic kidney disease;Heart Failure Reviews;2024-07-29

2. Early diagnosis of chronic kidney disease in patients with diabetes in France: multidisciplinary expert opinion, prevention value and practical recommendations;Postgraduate Medicine;2023-09-21

3. Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease;World Journal of Cardiology;2023-07-26